Published by
@ShahidNShah
@ShahidNShah
February 26 to February 28, 2024
Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States
The upcoming event, scheduled from Mon, 26 Feb 2024 to Wed, 28 Feb 2024, focuses on driving innovation in Discovery and Chemistry, Validating Clinical Proof-of-Concept, and Streamlining CMC of Conjugates with Novel Payloads and Formats. While traditional ADCs have shown success, they encounter challenges like limited payload capacities and significant toxicities. To overcome these limitations, drug developers are pushing boundaries by exploring unconventional conjugate drug designs. Companies such as VincerX Pharma, Dyne Therapeutics, and Orum Therapeutics are at the forefront, awaiting clinical validation with their novel payloads and targeting formats.
Read on next-gen-conjugates.com
Continue reading at next-gen-conjugates.com
February 26 to February 28, 2024
Steamboat Grand, 2300 Mount Werner Circle, Steamboat Springs, Colorado, 80487, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm